Intrinsic and acquired resistance mechanisms of alectinib in ALK rearranged cells

被引：0
|
作者：
Hibino, Yukiko [1 ]
Takaaki, Sasaki [1 ]
Minami, Yoshinori [1 ]
Janne, Pasi A. [2 ]
Ohsaki, Yoshinobu [1 ]
机构：
[1] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3720
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
    Katayama, Ryohei
    Shaw, Alice T.
    Khan, Tahsin M.
    Mino-Kenudson, Mari
    Solomon, Benjamin J.
    Halmos, Balazs
    Jessop, Nicholas A.
    Wain, John C.
    Yeo, Alan Tien
    Benes, Cyril
    Drew, Lisa
    Saeh, Jamal Carlos
    Crosby, Katherine
    Sequist, Lecia V.
    Iafrate, A. John
    Engelman, Jeffrey A.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (120)
  • [2] Mechanisms of acquired crizotinib resistance in ALK-rearranged lung cancers
    Katayama, Ryohei
    Shaw, Alice T.
    Khan, Tahsin M.
    Mino-Kenudson, Mari
    Iafrate, Anthony J.
    Engelman, Jeffrey A.
    CANCER RESEARCH, 2012, 72
  • [3] KRAS mutation as a mechanism of resistance to Alectinib in ALK rearranged NSCLC
    Batra, Ullas
    Nathany, Shrinidhi
    Sharma, Mansi
    Jain, Parveen
    Bansal, Abhishek
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 3
  • [4] Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK- Rearranged NSCLC
    Daniel, Catherine
    Callens, Celine
    Melaabi, Samia
    Bieche, Ivan
    Girard, Nicolas
    JTO CLINICAL AND RESEARCH REPORTS, 2020, 1 (04):
  • [5] Mechanisms of Acquired Resistance to the ALK Inhibitor Lorlatinib in ALK-Rearranged NSCLC Cell Lines
    Madsen, A.
    Jakobsen, K.
    Demuth, C.
    Sorensen, B.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2255 - S2255
  • [6] ACQUIRED L1196M MUTATION IN ALK GENE INDUCES ALECTINIB RESISTANCE IN A CASE OF REFRACTORY NPM-ALK REARRANGED ANAPLASTIC LARGE CELL LYMPHOMA
    Noguchi, Kazuhiro
    Ikawa, Yasuhiro
    Takenaka, Mika
    Sakai, Yuta
    Fujiki, Toshihiro
    Kuroda, Rie
    Sakai, Seisho
    Abe, Takatoshi
    Wada, Taizo
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [7] Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib
    Katayama, Ryohei
    Friboulet, Luc
    Koike, Sumie
    Lockerman, Elizabeth L.
    Khan, Tahsin M.
    Gainor, Justin F.
    Iafrate, A. John
    Takeuchi, Kengo
    Taiji, Makoto
    Okuno, Yasushi
    Fujita, Naoya
    Engelman, Jeffrey A.
    Shaw, Alice T.
    CLINICAL CANCER RESEARCH, 2014, 20 (22) : 5686 - 5696
  • [8] A molecular dynamics investigation into the mechanisms of alectinib resistance of three ALK mutants
    He, Muyang
    Li, Weikang
    Zheng, Qingchuan
    Zhang, Hongxing
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (07) : 5332 - 5342
  • [9] Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model
    Tsuji, Takahiro
    Ozasa, Hiroaki
    Aoki, Wataru
    Aburaya, Shunsuke
    Funazo, Tomoko
    Furugaki, Koh
    Yoshimura, Yasushi
    Ajimizu, Hitomi
    Okutani, Ryoko
    Yasuda, Yuto
    Nomizo, Takashi
    Uemasu, Kiyoshi
    Hasegawa, Koichi
    Yoshida, Hironori
    Yagi, Yoshitaka
    Nagai, Hiroki
    Sakamori, Yuichi
    Ueda, Mitsuyoshi
    Hirai, Toyohiro
    Kim, Young Hak
    MOLECULAR CANCER RESEARCH, 2019, 17 (01) : 212 - 224
  • [10] Adjuvant Alectinib in ALK-Rearranged NSCLC - Here and Now
    Passaro, Antonio
    Peters, Solange
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (14): : 1325 - 1327
12345